Sign up to save your podcasts
Or
Share The Kingfisher Trial of Brolucizumab for DME
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Kingfisher Trial of Brolucizumab for DME
We discuss the results of the Kingfisher trail, a study employing broluizumab q4 weeks for the treatment of diabetic macular edema with Dr. Mark Barakat, Assistant Clinical Profess of Ophthalmology, University of Arizona College of Medicine Phoenix.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the results of the Kingfisher trail, a study employing broluizumab q4 weeks for the treatment of diabetic macular edema with Dr. Mark Barakat, Assistant Clinical Profess of Ophthalmology, University of Arizona College of Medicine Phoenix.
More shows like Retina Synthesis
View all
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners